Abstract
A series of potent p38 inhibitors based on the dihydroquinazoline scaffold was synthesized using a novel Pd-catalyzed cyclization reaction of aryl-benzyl ureas. Optimization of this compound class led to compound 20, which inhibits p38alpha in vitro with IC(50)=14 nM and is active in the mouse TNFalpha-release model.
MeSH terms
-
Animals
-
Catalysis
-
Cyclization
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Lead / chemistry*
-
Lead / pharmacology
-
Mice
-
Mitogen-Activated Protein Kinases / antagonists & inhibitors*
-
Mitogen-Activated Protein Kinases / metabolism
-
Quinazolines / chemical synthesis*
-
Quinazolines / pharmacology
-
Urea / chemical synthesis*
-
Urea / pharmacology
-
p38 Mitogen-Activated Protein Kinases
Substances
-
Enzyme Inhibitors
-
Quinazolines
-
Lead
-
Urea
-
Mitogen-Activated Protein Kinases
-
p38 Mitogen-Activated Protein Kinases